Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in treatment for narcolepsy
Lucie Barateau, Yves Dauvilliers
Therapeutic Advances in Neurological Disorders (2019) Vol. 12
Open Access | Times Cited: 84

Showing 26-50 of 84 citing articles:

pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy
Noeen Sarfraz, David Okuampa, Hannah Hansen, et al.
Health psychology research (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 13
A multicenter, double-blind, placebo-controlled, randomized, Phase 1b crossover trial comparing two doses of ulotaront with placebo in the treatment of narcolepsy-cataplexy
Steven T. Szabo, Seth C. Hopkins, Robert Lew, et al.
Sleep Medicine (2023) Vol. 107, pp. 202-211
Open Access | Times Cited: 7
Changes in Sleep Pattern During the COVID-19 Lockdown in Patients With Narcolepsy, Idiopathic Hypersomnia, and Restless Legs Syndrome
Lucie Barateau, Sofiène Chenini, Anna Laura Rassu, et al.
Neurology (2022) Vol. 99, Iss. 14
Closed Access | Times Cited: 11
From circadian clock mechanism to sleep disorders and jet lag: Insights from a computational approach
Albert Goldbeter, Jean‐Christophe Leloup
Biochemical Pharmacology (2021) Vol. 191, pp. 114482-114482
Closed Access | Times Cited: 14
Sleep Disorders in dogs: A Pathophysiological and Clinical Review
Alejandra Mondino, Luis Delucchi, Adam J. Moeser, et al.
Topics in companion animal medicine (2021) Vol. 43, pp. 100516-100516
Closed Access | Times Cited: 13
Article Commentary: Pharmacokinetic and Pharmacodynamic of the Cognitive Enhancer Modafinil: Relevant Clinical and Forensic Aspects
Ana Catarina Sousa, Ricardo Jorge Dinis‐Oliveira
Substance Abuse (2020) Vol. 41, Iss. 2, pp. 155-173
Closed Access | Times Cited: 14
The sodium in sodium oxybate: is there cause for concern?
Alon Y. Avidan, Clete A. Kushida
Sleep Medicine (2020) Vol. 75, pp. 497-501
Open Access | Times Cited: 13
Optimal dose determination of enerisant (TS-091) for patients with narcolepsy: two randomized, double-blind, placebo-controlled trials
Yuichi Inoue, Makoto Uchiyama, Hideo Umeuchi, et al.
BMC Psychiatry (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Pharmacokinetics of FT218, a Once-Nightly Sodium Oxybate Formulation in Healthy Adults
David Seiden, Charles R. Tyler, Jordan Dubow
Clinical Therapeutics (2021) Vol. 43, Iss. 4, pp. 672.e1-672.e14
Open Access | Times Cited: 11
Exploring the Literature on Narcolepsy: Insights into the Sleep Disorder That Strikes during the Day
Ana-Maria Mațotă, Andrei Bordeianu, Emilia Severin, et al.
NeuroSci (2023) Vol. 4, Iss. 4, pp. 263-279
Open Access | Times Cited: 4
Sex-dependent effects of monomeric α-synuclein on calcium and cell death of lateral hypothalamic mouse neurons are altered by orexin
Sara Bohid, Lara Kamal Ali, César Ramón Romero Leguizamón, et al.
Molecular and Cellular Neuroscience (2024) Vol. 129, pp. 103934-103934
Open Access | Times Cited: 1
Evaluating pitolisant as a narcolepsy treatment option
Stefano de Biase, Gaia Pellitteri, Gian Luigi Gigli, et al.
Expert Opinion on Pharmacotherapy (2020) Vol. 22, Iss. 2, pp. 155-162
Closed Access | Times Cited: 11
A comparison of mood, quality of life and executive function among narcolepsy type 1 patients with or without ADHD symptoms in China
Shan Qu, Peipei Wang, Mengmeng Wang, et al.
Sleep Medicine (2022) Vol. 97, pp. 47-54
Closed Access | Times Cited: 6
Evaluation of the efficacy of the hypocretin/orexin receptor agonists TAK‐925 and ARN‐776 in narcoleptic orexin/tTA; TetO‐DTA mice
Yu Sun, Alok Ranjan, Ryan K. Tisdale, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 4
Open Access | Times Cited: 3
Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials
Gerard Meskill, Craig W. Davis, Donna Zarycranski, et al.
CNS Drugs (2021) Vol. 36, Iss. 1, pp. 61-69
Open Access | Times Cited: 8
How treatable is narcolepsy with current pharmacotherapy and what does the future hold?
Gaia Pellitteri, Stefano de Biase, Mariarosaria Valente, et al.
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 12, pp. 1517-1520
Closed Access | Times Cited: 7
Modulation of sleep behavior in zebrafish larvae by pharmacological targeting of the orexin receptor
Marie Pardon, Pieter Claes, Sarah Druwé, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 5
Clinical Characteristics of Cataplectic Attacks in Type 1 Narcolepsy
Arpita Parmar, Brian J. Murray, Indra Narang
Current Neurology and Neuroscience Reports (2020) Vol. 20, Iss. 9
Closed Access | Times Cited: 6
Emerging therapeutic targets for narcolepsy
Marieke Vringer, Birgitte Rahbek Kornum
Expert Opinion on Therapeutic Targets (2021) Vol. 25, Iss. 7, pp. 559-572
Closed Access | Times Cited: 6
Metabolic-Syndrome-Related Comorbidities in Narcolepsy Spectrum Disorders: A Preliminary Cross-Sectional Study in Japan
Kunihiro Futenma, Yoshikazu Takaesu, Masaki Nakamura, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 10, pp. 6285-6285
Open Access | Times Cited: 4
Psychotic Episode and Schizophrenia in Slovakian Narcolepsy Database
Eva Feketeová, Jozef Dragašek, Katarina Klobučníková, et al.
Brain Sciences (2022) Vol. 13, Iss. 1, pp. 43-43
Open Access | Times Cited: 4
Time to Onset of Response to Pitolisant for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients With Narcolepsy: An Analysis of Randomized, Placebo-Controlled Trials
Nathaniel F. Watson, Craig W. Davis, Donna Zarycranski, et al.
CNS Drugs (2021) Vol. 35, Iss. 12, pp. 1303-1315
Open Access | Times Cited: 5
Impact of L-carnitine in narcolepsy treatment: a systematic review on the effectiveness and safety
Cristina Salles, Maria Clara Freitas, Miguel Meira e Cruz
Sleep Science (2022) Vol. 15, Iss. S 01, pp. 278-284
Open Access | Times Cited: 3
Pharmacotherapy only? Overview of available treatments for sleep disorders
Karolina Górska, Katarzyna Antoniak-Sobczak, Lucyna Ścisło, et al.
Problemy Pielęgniarstwa (2024) Vol. 32, Iss. 1, pp. 7-14
Open Access
Eurycoma longifolia (Tongkat Ali) supplementation enhances sleep and wake consolidation in wild-type, but not in narcoleptic mice
Noriaki Sakai, Kazuhiro Komi, Naoya Nishino, et al.
SLEEP Advances (2024) Vol. 5, Iss. 1
Open Access

Scroll to top